Study demonstrates that exercise following bariatric surgery provides health benefits

December 01, 2014

ORLANDO, Fla., December 1, 2014 - A new study by researchers at the Florida Hospital - Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI-MD) shows that patients who moderately exercise after bariatric surgery (weight-loss surgery) gain additional health improvements in glucose metabolism and cardiorespiratory fitness compared to patients who lead a sedentary lifestyle after surgery. The findings confirm the physiological and potential clinical benefits of adding an exercise regime following weight-loss surgery.

"This is the first randomized, controlled clinical study that examines the effects of exercise on insulin sensitivity and other cardio and metabolic risk factors following bariatric surgery," said Bret Goodpaster, Ph.D., director of the Exercise Metabolism Core, senior investigator at the TRI-MD, and professor at Sanford-Burnham Medical Research Institute. "The data support the inclusion of an exercise program following bariatric surgery to further enhance the health of individuals who opt for surgery to lose weight."

Study Results

The study, published in The Journal of Clinical Investigation, examined two groups of patients that had recently undergone Roux-en-Y bypass (RYGB) bariatric surgery. The first group participated in an education program after surgery and the second group participated in the education program plus an exercise program after surgery. The education program consisted of six sessions per month and included lectures, discussions, and demonstrations providing up-to-date information on topics such as medication use, nutrition, and upper-body stretching. The exercise group performed 120 minutes per week of exercise. A total of 119 participants completed the 24-week study.

Compared to the education group, the exercise group showed significant improvement in insulin sensitivity and glucose metabolism. Low insulin sensitivity and poor glucose metabolism can cause type 2 diabetes, and are associated with the risk of developing the disease. Both are common in pre-diabetes--a condition that means your blood-sugar level is higher than normal but not high enough to be classified as type 2 diabetes.

The exercise group also showed significantly improved cardiorespiratory fitness--a reference to the ability of the circulatory and respiratory system to supply oxygen to muscles during exercise. Cardiovascular fitness reduces the risk of heart disease, type 2 diabetes, lung cancer, and stroke, and is an effective predictor of future mortality.

Although both groups lost weight--approximately 50 lbs.--as a result of RYGB surgery, there were no differences in the total amount of weight loss between the two groups.

"Importantly, our study showed that aerobic exercise is feasible in this population--a result that directly counters the perception that severely obese individuals cannot respond to lifestyle interventions," said Goodpaster. "Moreover, we have identified specific, non-weight-related health benefits that exercise confers on these individuals. We look forward to additional studies to determine the optimal amount and type of exercise that produces the best physiological results."

Bariatric Surgery

Bariatric surgery is a surgical procedure recommended by the U.S. National Institutes of Health (NIH) for clinically obese individuals that have a body mass index (BMI), a measurement based on height and weight, of 40.That translates to 294 pounds for someone who is six feet tall, and 218 pounds for someone who is five feet two. More than 200,000 individuals undergo bariatric surgery each year in the U.S.

The Roux-end-Y bypass (RYGB) gastric bypass surgery is the most commonly performed metabolic surgery in the U.S. The surgery involves taking a small part of the stomach to create a new stomach pouch, roughly the size of an egg. The smaller stomach is connected to the small intestine at a location that limits the amount of food you can eat and causes food to bypass the stomach and small intestine to reduce the amount of fat and calories you can absorb from food.
-end-
The study was performed in collaboration with the Division of Endocrinology and Metabolism, Department of Medicine, Department of Health and Physical Activity, and the Department of Surgery at the University of Pittsburgh, Pa., and the Department of Kinesiology, East Carolina University, Greenville, N.C.

This study was funded by the NIH/National Institute of Diabetes and Digestive Kidney Diseases (RO1 DK078192) and was registered at http://www.clinicaltris.gov (Trial ID NCT00692367).

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center, its NIH-designated Neuroscience Center Cores, and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,100 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at sanfordburnham.org.

Sanford-Burnham can also be found on Facebook at facebook.com/sanfordburnham and on Twitter @sanfordburnham.

About Florida Hospital

Opened in 1908, Florida Hospital is a faith-based institution focused on providing whole person care. It is one of the largest not-for-profit hospitals in the country, caring for more than a million patient visits per year - more than any other hospital in the country, according to the American Hospital Association. The more than 2,500-bed system is comprised of eight hospitals, including the Walt Disney Pavilion at Florida Hospital for Children, and dozens outpatient facilities and urgent care centers known as Centra Cares across the state.

With advanced research and industry partnerships, Florida Hospital seeks to extend and improve the quality of lives through the translation of fundamental scientific discoveries to the diagnosis and treatment of human disease.

About the Translational Research Institute for Metabolism and Diabetes

The TRI-MD is a joint venture between Florida Hospital and Sanford-Burnham Medical Research Institute that bridges the gap between discovery research and clinical care, with particular focus on diabetes and obesity. How exercise works, or why exercise is beneficial for health is not well understood, and how metabolism plays a role in obesity, diabetes, and cardiovascular disease remains unclear. Understanding these mechanisms require an interdisciplinary approach, hence the TRI-MD and this Florida Hospital and Sanford-Burnham Medical Research Institute collaboration.

Sanford-Burnham Prebys Medical Discovery Institute

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.